Pauck D, Picard D, Maue M, Taban K, Marquardt V, Bl?mel L, Bartl J, Qin N, Kubon N, Sch?ndorf D, Meyer FD, Theruvath J, Mitra S, Hasselblatt M, Fr?hwald MC, Reifenberger G, Remke M. An in vitro pharmacogenomic approach reveals subtype-specific therapeutic vulnerabilities in atypical teratoid/rhabdoid tumors (AT/RT). Pharmacol Res. 2025 Mar; 213:107660.